Johnson & Johnson (NYSE: JNJ) shares trade actively on the New York Stock Exchange at approximately $272.48 per share. As a foundational healthcare blue-chip giant encompassing massive pharmaceutical and medical technology divisions, its valuation shifts continuously during trading sessions based on institutional volume, quarterly earnings reports, and broader macroeconomic sector performance.